Position in LQDA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$23,589,311
+$2,428,041 QoQ
Shares Held
625,048
+1.9% QoQ
Ownership
0.703%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
17 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Derivatives in LQDA
reported options exposure · as of Sep 30, 2025CallValue
$1,655,472
CallShares
72,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BOOTHBAY FUND MANAGEMENT, LLC holds $50,237,325 across 12 Drug Manufacturers - Specialty & Generic names. LQDA ranks #1 (47.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
This page
|
625,048 | $23,589,311 | |
| 2 | ANIK |
Anika Therapeutics, Inc.
|
529,503 | $7,677,793 | |
| 3 | HROW |
Harrow, Inc.
|
158,110 | $5,574,958 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
40,743 | $3,133,136 | |
| 5 | VTRS |
Viatris Inc
|
214,577 | $2,898,935 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
88,379 | $2,661,975 | |
| 7 | CRON |
Cronos Group Inc.
|
601,859 | $1,510,666 | |
| 8 | ETON |
Eton Pharmaceuticals, Inc.
|
55,605 | $1,372,331 |
All Filings in LQDA
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,589,311 | 625,048 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $21,161,270 | 613,548 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $15,831,451 | 696,194 | Shares | Other | 2025-11-14 | |
| 2025-09-30 | $1,655,472 | 72,800 | Call | Other | 2025-11-14 | |
| 2025-06-30 | $8,209,744 | 658,888 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $9,777,376 | 662,873 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $6,569,818 | 558,658 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $5,586,580 | 558,658 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $6,703,896 | 558,658 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $8,240,205 | 558,658 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $6,720,655 | 558,658 | Shares | Other | 2024-02-14 | |
| 2022-06-30 | $1,500,912 | 344,246 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $165,175 | 23,005 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $157,963 | 32,436 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $243,409 | 88,192 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $313,564 | 109,638 | Shares | Other | 2021-08-17 | |
| 2021-03-31 | $265,546 | 98,716 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $291,212 | 98,716 | Shares | Other | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||